Stockreport

Kinea Bio Secures $1.1M Jain Foundation Investment and Solid Biosciences Capsid License to Advance Novel Gene Therapy for Dysferlinopathy, a Rare Neuromuscular Disease [Yahoo! Finance]

Solid Biosciences Inc.  (SLDB) 
Last solid biosciences inc. earnings: 8/14 07:25 am Check Earnings Report
US:NASDAQ Investor Relations: investors.solidbio.com/investor-relations
PDF SEATTLE, September 23, 2025 BUSINESS WIRE )--Kinea Bio Inc., a biotechnology company dedicated to developing transformative genetic medicines, today announced two major [Read more]